GlassScriptPhysician profile
Ammar X Khalifa
NPI 1780677948
$8,483.79
in general payments reported to CMS, 2019-2025
66 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.00 · 2020: $405 · 2021: $1,358 · 2022: $2,182 · 2023: $1,413 · 2024: $1,559 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,477.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $865.43 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $734.80 | 2021-2025 | Freestyle Libre 3 |
| Abbvie INC. | $611.78 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $493.89 | 2020-2025 | Jardiance |
| Novo Nordisk INC | $459.63 | 2020-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $421.04 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $339.16 | 2021-2025 | |
| Corcept Therapeutics | $280.91 | 2022-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $273.36 | 2020-2023 | Xarelto |
| Amgen INC. | $215.04 | 2021-2025 | Tavneos, Evenity, Prolia |
| Shield Therapeutics INC | $207.53 | 2025 | |
| Merck Sharp & Dohme LLC | $207.32 | 2021-2023 | Belsomra, Steglatro, Steglujan |
| Astrazeneca Pharmaceuticals LP | $197.83 | 2020-2024 | Farxiga, Airsupra |
| Pfizer INC. | $183.22 | 2021-2025 | |
| Travere Therapeutics, INC. | $165.28 | 2022-2025 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $128.03 | 2020-2025 | Afrezza |
| Mallinckrodt Hospital Products INC. | $125.55 | 2020-2025 | Acthar |
| Calliditas Therapeutics US INC. | $125.16 | 2025 | Tarpeyo |
| Vifor Pharma, INC. | $122.50 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $122.07 | 2022-2025 | Gvoke Hypopen, Keveyis, Recorlev |
| Otsuka America Pharmaceutical, INC. | $121.28 | 2023-2025 | Rexulti, Nuedexta |
| Lundbeck LLC | $109.20 | 2024 | Rexulti |
| Daiichi Sankyo INC. | $108.81 | 2021-2024 | Injectafer |
| Ardelyx, INC. | $107.86 | 2024-2025 | Ibsrela |
| Sanofi-Aventis U.S. LLC | $105.54 | 2022-2023 | |
| Ani Pharmaceuticals, INC. | $104.52 | 2023-2024 | Purified Cortrophin Gel |
| Corium, LLC | $89.69 | 2022-2023 | Adlarity |
| Medtronic, INC. | $81.43 | 2021-2025 | Minimed 780g |
| Biogen, INC. | $81.27 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $68.35 | 2020-2025 | Unithroid |
| Nestle Healthcare Nutrition INC. | $63.97 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $61.92 | 2021-2023 | |
| Ibsa Pharma INC. | $61.46 | 2020-2025 | Tirosint, Licart, Flector |
| Ascensia Diabetes Care US INC. | $60.65 | 2024 | |
| Amarin Pharma, INC. | $56.48 | 2020-2021 | |
| Mylan Specialty L.P. | $53.60 | 2022-2023 | Yupelri |
| Sunovion Pharmaceuticals INC. | $52.10 | 2019-2022 | |
| Genzyme Corporation | $51.92 | 2021-2024 | |
| Axsome Therapeutics, INC. | $49.67 | 2023-2024 | Auvelity |
| Insulet Corporation | $47.08 | 2019-2022 | |
| Fresenius USA Marketing, INC. | $46.95 | 2020-2025 | Velphoro |
| Tandem Diabetes Care, INC. | $43.23 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $37.09 | 2022 | |
| Sun Pharmaceutical Industries INC. | $35.98 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $33.47 | 2023-2025 | Ingrezza |
| Globus Medical, INC. | $32.80 | 2025 | Senza |
| Idorsia Pharmaceuticals US INC | $31.38 | 2023-2024 | Quviviq |
| Melinta Therapeutics, LLC | $31.22 | 2024 | Kimyrsa, Orbactiv |
| Paratek Pharmaceuticals, INC. | $30.66 | 2024 | Nuzyra |
| Glaxosmithkline, LLC. | $26.24 | 2021 | |
| Sumitomo Pharma America, INC. | $25.53 | 2025 | Gemtesa |
| Medtronic Minimed, INC. | $25.18 | 2020 | |
| Aimmune Therapeutics, INC. | $24.69 | 2024 | |
| Nevro Corp. | $24.56 | 2024 | Senza |
| Eisai INC. | $23.70 | 2021 | |
| Beta Bionics, INC. | $22.54 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Radius Health, INC. | $21.77 | 2020 | |
| Kyowa Kirin, INC. | $20.74 | 2021 | |
| Nxstage Medical, INC. | $19.99 | 2025 | Nxstage System One |
| Antares Pharma, INC. | $18.49 | 2025 | Xyosted |
| Scilex Pharmaceuticals INC. | $17.95 | 2024 | |
| Cequr Corporation | $16.74 | 2023 | Cequr Simplicity |
| Exact Sciences Corporation | $14.88 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $14.25 | 2022 | |
| Opko Pharmaceuticals, LLC | $13.76 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.67 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Khalifa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.